Postpartum acute renal failure: a multicenter study of risk factors in patients admitted to ICU

Annals of Intensive Care

Table 5 Frequency of ARF according to the type and dose of treatments

	ARF groupn= 68	No ARF groupn= 114	pvalue
Crystalloids
n = 121	52 (93)	69 (84)	0.12
mL^a	2,000 [1,500 to 3,000]	2,000 [1,000 to 2,500]	0.58
Artificial colloids
n = 100	40 (74)	60 (71)	0.7
mL^a	1,000 [1,000 to 1,750]	1,000 [1,000 to 2,000]	0.66
Hyperoncotic albumin
n = 32	20 (29)	12 (10)	0.0012
mL^a	250 [200 to 400]	200 [200 to 300]	0.52
Albumin 4%
n = 24	8 (12)	16 (14)	0.66
mL^a	750 [500 to 1,375]	750 [500 to 1,000]	0.94
Packed red cells
n = 107	44 (65)	63 (56)	0.26
mL^a	800 [600 to 120]	1,000 [600 to 1,600]	0.11
Platelets concentrates
n = 68	25 (38)	43 (38)	0.94
n ^a	1 [1 to 2]	1 [1 to 2]	0.55
Fresh frozen plasma (FFP)
n = 94	37 (56)	57 (51)	0.54
n ^a	4 [3 to 6]	5 [3 to 7]	0.11
Fibrinogen concentrate
n = 107	45 (66)	62 (57)	0.24
g^a	4.50 [3 to 7.5]	5.5 [3 to 7.5]	0.75
Activated factor VII
n = 7	4 (6)	3 (3)	NA
Tranexamic acid
n = 79	37 (54)	42 (38)	0.03
g^a	5 [4 to 7]	5 [3 to 9]	0.66
Antihypertensive drugs in ICU
n = 101	43 (64)	58 (52)	0.10
n ^a	1 [0 to 3]	1 [0 to 2]	0.03
Diuretics
n = 73	36 (53)	37 (32)	0.006
ACE inhibitors
n = 50	24 (35)	26 (23)	0.079
Radio-contrast media
n = 27	11 (16)	16 (14)	0.71
Aminoglycosides
n = 33	12 (18)	21 (19)	0.87

Data are N (%) for qualitative variables. Frequency is given in brackets considering missing data. ^aQuantitative variables are presented as median [space interquartile range: 25th to 75th percentiles]. mL: milliter; n: number; g: grams; NA = not applicable.